Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982492priorityCriticalpatent/ECSP982492A/en
Publication of ECSP982492ApublicationCriticalpatent/ECSP982492A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicinal Preparation
(AREA)
Abstract
Se revela un método que comprende la administarción de un PEG12000-IFN alfa conjugado a un individuo que padece una infección viral, preferentemente hepatitis crónica C, susceptible de un tratamiento con interferón alfa.A method is disclosed comprising administering a conjugated PEG12000-IFN alpha to an individual suffering from a viral infection, preferably chronic hepatitis C, susceptible to treatment with interferon alpha.
Pharmaceutical composition comprising a pegylated conjugate of interferon alfa and ribavirin, useful in the preparation of a medicament for chronic hepatitis C infections.